{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T06:35:33Z","timestamp":1789022133694,"version":"build-2803163510"},"reference-count":71,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","advancesinanesthesia.com","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advances in Anesthesia"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.aan.2024.07.002","type":"journal-article","created":{"date-parts":[[2024,8,28]],"date-time":"2024-08-28T02:12:14Z","timestamp":1724811134000},"page":"1-26","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Perioperative Considerations for Patients on GLP1 Agonists"],"prefix":"10.1016","volume":"42","author":[{"given":"Beth A.","family":"VanderWielen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Brian Beam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.aan.2024.07.002_bib1","doi-asserted-by":"crossref","first-page":"260","DOI":"10.3389\/fendo.2019.00260","article-title":"From the Incretin Concept and the Discovery of GLP-1 to Today's Diabetes Therapy","volume":"10","author":"Holst","year":"2019","journal-title":"Front Endocrinol"},{"issue":"2","key":"10.1016\/j.aan.2024.07.002_bib2","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1210\/endrev\/bnaa032","article-title":"Revisiting the Complexity of GLP-1 Action from Sites of Synthesis to Receptor Activation","volume":"42","author":"McLean","year":"2021","journal-title":"Endocr Rev"},{"issue":"7","key":"10.1016\/j.aan.2024.07.002_bib3","doi-asserted-by":"crossref","first-page":"R200","DOI":"10.1530\/EC-21-0130","article-title":"How glucagon-like peptide 1 receptor agonists work","volume":"10","author":"Andreasen CR, Andersen A, Knop FK, Vilsboll T","year":"2021","journal-title":"Endocr Connect"},{"key":"10.1016\/j.aan.2024.07.002_bib4","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.molmet.2019.09.010","article-title":"Glucagon-like peptide 1 (GLP-1)","volume":"30","author":"Muller","year":"2019","journal-title":"Mol Metab"},{"issue":"4","key":"10.1016\/j.aan.2024.07.002_bib5","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1007\/s00125-005-1705-7","article-title":"Glucagon-like peptide-1 mediates the therapeutic actions of DPP-IV inhibitors","volume":"48","author":"Holst","year":"2005","journal-title":"Diabetologia"},{"key":"10.1016\/j.aan.2024.07.002_bib6","unstructured":"IBM Watson Health information, Available at: https:\/\/www.micromedexsolutions.com\/ (Accessed 28 March 2024)."},{"issue":"4","key":"10.1016\/j.aan.2024.07.002_bib7","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1080\/17446651.2023.2209176","article-title":"Pharmacotherapy for obesity: recent evolution and implications for cardiovascular risk reduction","volume":"18","author":"Maki","year":"2023","journal-title":"Expet Rev Endocrinol Metabol"},{"key":"10.1016\/j.aan.2024.07.002_bib8","doi-asserted-by":"crossref","first-page":"3961","DOI":"10.2147\/DMSO.S392952","article-title":"Semaglutide 2.4 Mg for the management of overweight and obesity: systematic literature review and meta-analysis","volume":"15","author":"Smith","year":"2022","journal-title":"Diabetes Metab Syndr Obes"},{"issue":"12","key":"10.1016\/j.aan.2024.07.002_bib9","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1056\/NEJMoa2028395","article-title":"A\u00a0placebo-controlled trial of subcutaneous semaglutide in nonalcoholic steatohepatitis","volume":"384","author":"Newsome","year":"2021","journal-title":"N\u00a0Engl J Med"},{"issue":"21","key":"10.1016\/j.aan.2024.07.002_bib10","doi-asserted-by":"crossref","DOI":"10.3390\/nu14214673","article-title":"Once-weekly subcutaneous semaglutide improves fatty liver disease in patients with type 2 diabetes: a 52-week prospective real-life study","volume":"14","author":"Volpe","year":"2022","journal-title":"Nutrients"},{"issue":"9","key":"10.1016\/j.aan.2024.07.002_bib11","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1093\/ndt\/gfad009","article-title":"The rationale, design and baseline data of FLOW, a kidney outcomes trial with once-weekly semaglutide in people with type 2 diabetes and chronic kidney disease","volume":"38","author":"Rossing","year":"2023","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.aan.2024.07.002_bib13","doi-asserted-by":"crossref","first-page":"106550","DOI":"10.1016\/j.phrs.2022.106550","article-title":"Glucagon-like peptide-1 (GLP-1) receptor agonists and neuroinflammation: Implications for neurodegenerative disease treatment","volume":"186","author":"Kopp","year":"2022","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.aan.2024.07.002_bib14","first-page":"S41","article-title":"Multicenter, Randomized, Placebo-controlled, Double-blind, Parallelgroup Proof-of-concept Study of Lixisenatide in Patients with Early Parkinson's Disease (PD): The LIXIPARK Trial (NCT03439943)","volume":"38","author":"Meissner","year":"2023","journal-title":"Movement Disord"},{"issue":"1","key":"10.1016\/j.aan.2024.07.002_bib15","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s10194-023-01631-z","article-title":"Treatment with GLP-1 receptor agonists is associated with significant weight loss and favorable headache outcomes in idiopathic intracranial hypertension","volume":"24","author":"Krajnc","year":"2023","journal-title":"J\u00a0Headache Pain"},{"issue":"12","key":"10.1016\/j.aan.2024.07.002_bib16","doi-asserted-by":"crossref","first-page":"2993","DOI":"10.1038\/s41591-023-02634-8","article-title":"GLP-1 receptor agonists are promising but unproven treatments for alcohol and substance use disorders","volume":"29","author":"Leggio","year":"2023","journal-title":"Nat Med"},{"issue":"12","key":"10.1016\/j.aan.2024.07.002_bib17","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1056\/NEJMoa2306963","article-title":"Semaglutide in patients with heart failure with preserved ejection fraction and obesity","volume":"389","author":"Kosiborod","year":"2023","journal-title":"N\u00a0Engl J Med"},{"issue":"24","key":"10.1016\/j.aan.2024.07.002_bib18","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1056\/NEJMoa2307563","article-title":"Semaglutide and cardiovascular outcomes in obesity without diabetes","volume":"389","author":"Lincoff","year":"2023","journal-title":"N\u00a0Engl J Med"},{"issue":"15","key":"10.1016\/j.aan.2024.07.002_bib19","first-page":"1434","article-title":"Tirzepatide once weekly for the treatment of obesity","volume":"387","author":"Jastreboff","year":"2022","journal-title":"Reply. N Engl J Med"},{"issue":"10","key":"10.1016\/j.aan.2024.07.002_bib20","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1056\/NEJMoa2108269","article-title":"Cardiovascular and renal outcomes with efpeglenatide in type 2 diabetes","volume":"385","author":"Gerstein","year":"2021","journal-title":"N\u00a0Engl J Med"},{"issue":"11","key":"10.1016\/j.aan.2024.07.002_bib21","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1056\/NEJMoa2032183","article-title":"Once-weekly semaglutide in adults with overweight or obesity","volume":"384","author":"Wilding","year":"2021","journal-title":"N\u00a0Engl J Med"},{"issue":"10193","key":"10.1016\/j.aan.2024.07.002_bib22","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0140-6736(19)31149-3","article-title":"Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial","volume":"394","author":"Gerstein","year":"2019","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.aan.2024.07.002_bib23","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1056\/NEJMoa1901118","article-title":"Oral semaglutide and cardiovascular outcomes in patients with type 2 diabetes","volume":"381","author":"Husain","year":"2019","journal-title":"N\u00a0Engl J Med"},{"issue":"13","key":"10.1016\/j.aan.2024.07.002_bib24","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1056\/NEJMoa1612917","article-title":"Effects of once-weekly exenatide on cardiovascular outcomes in type 2 diabetes","volume":"377","author":"Holman","year":"2017","journal-title":"N\u00a0Engl J Med"},{"issue":"19","key":"10.1016\/j.aan.2024.07.002_bib25","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1056\/NEJMoa1607141","article-title":"Semaglutide and cardiovascular outcomes in patients with type 2 diabetes","volume":"375","author":"Marso","year":"2016","journal-title":"N\u00a0Engl J Med"},{"issue":"18","key":"10.1016\/j.aan.2024.07.002_bib26","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1056\/NEJMc1611289","article-title":"Liraglutide and cardiovascular outcomes in type 2 diabetes","volume":"375","author":"Alvarez-Villalobos","year":"2016","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.aan.2024.07.002_bib27","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1411892","article-title":"A\u00a0randomized, controlled trial of 3.0 mg of liraglutide in weight management","volume":"373","author":"Pi-Sunyer","year":"2015","journal-title":"N\u00a0Engl J Med"},{"issue":"Suppl 1","key":"10.1016\/j.aan.2024.07.002_bib28","first-page":"43","article-title":"Safety and tolerability of once-weekly GLP-1 receptor agonists in type 2 diabetes","volume":"45","author":"Trujillo","year":"2020","journal-title":"J\u00a0Clin Pharm Therapeut"},{"issue":"Suppl 2","key":"10.1016\/j.aan.2024.07.002_bib29","doi-asserted-by":"crossref","first-page":"S279","DOI":"10.2337\/dc11-s231","article-title":"Long-acting glucagon-like peptide 1 receptor agonists: a review of their efficacy and tolerability","volume":"34","author":"Garber","year":"2011","journal-title":"Diabetes Care"},{"issue":"9548","key":"10.1016\/j.aan.2024.07.002_bib30","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1016\/S0140-6736(06)69705-5","article-title":"The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes","volume":"368","author":"Drucker","year":"2006","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.aan.2024.07.002_bib31","doi-asserted-by":"crossref","first-page":"e12278","DOI":"10.1002\/anr3.12278","article-title":"Pulmonary aspiration of gastric contents in two patients taking semaglutide for weight loss","volume":"12","author":"Avraham","year":"2024","journal-title":"Anaesth Rep"},{"key":"10.1016\/j.aan.2024.07.002_bib32","author":"Beam"},{"issue":"8","key":"10.1016\/j.aan.2024.07.002_bib33","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1007\/s12630-023-02521-3","article-title":"Regurgitation under anesthesia in a fasted patient prescribed semaglutide for weight loss: a case report","volume":"70","author":"Gulak","year":"2023","journal-title":"Can J Anaesth"},{"issue":"8","key":"10.1016\/j.aan.2024.07.002_bib34","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1007\/s12630-023-02440-3","article-title":"Semaglutide, delayed gastric emptying, and intraoperative pulmonary aspiration: a case report","volume":"70","author":"Klein","year":"2023","journal-title":"Can J Anaesth"},{"issue":"7","key":"10.1016\/j.aan.2024.07.002_bib35","first-page":"e42153","article-title":"Anesthesia Considerations for a Patient on Semaglutide and Delayed Gastric Emptying","volume":"15","author":"Fujino","year":"2023","journal-title":"Cureus"},{"issue":"2","key":"10.1016\/j.aan.2024.07.002_bib36","doi-asserted-by":"crossref","first-page":"e37","DOI":"10.1016\/j.bja.2023.05.005","article-title":"Clinically significant emesis in a patient taking a long-acting GLP-1 receptor agonist for weight loss","volume":"131","author":"Weber","year":"2023","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.aan.2024.07.002_bib37","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/5584_2020_496","article-title":"Effects of GLP-1 and Its Analogs on Gastric Physiology in Diabetes Mellitus and Obesity","volume":"1307","author":"Maselli","year":"2021","journal-title":"Adv Exp Med Biol"},{"issue":"5","key":"10.1016\/j.aan.2024.07.002_bib38","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.2337\/db10-0474","article-title":"Rapid tachyphylaxis of the glucagon-like peptide 1-induced deceleration of gastric emptying in humans","volume":"60","author":"Nauck","year":"2011","journal-title":"Diabetes"},{"issue":"4","key":"10.1016\/j.aan.2024.07.002_bib39","first-page":"G920","article-title":"Glucagon-like peptide-1 inhibits gastric emptying via vagal afferent-mediated central mechanisms","volume":"273","author":"Imeryuz","year":"1997","journal-title":"Am J Physiol"},{"issue":"1","key":"10.1016\/j.aan.2024.07.002_bib40","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/BF02090069","article-title":"Inter- and intrasubject variability of solid and liquid gastric emptying parameters. A scintigraphic study in healthy subjects and diabetic patients","volume":"39","author":"Lartigue","year":"1994","journal-title":"Dig Dis Sci"},{"issue":"3","key":"10.1016\/j.aan.2024.07.002_bib41","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1111\/dom.13120","article-title":"Semaglutide improves postprandial glucose and lipid metabolism, and delays first-hour gastric emptying in subjects with obesity","volume":"20","author":"Hjerpsted","year":"2018","journal-title":"Diabetes Obes Metabol"},{"issue":"3","key":"10.1016\/j.aan.2024.07.002_bib42","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1111\/dom.14280","article-title":"The effect of semaglutide 2.4 mg once weekly on energy intake, appetite, control of eating, and gastric emptying in adults with obesity","volume":"23","author":"Friedrichsen","year":"2021","journal-title":"Diabetes Obes Metabol"},{"issue":"5","key":"10.1016\/j.aan.2024.07.002_bib43","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1111\/dom.13956","article-title":"Exenatide once weekly slows gastric emptying of solids and liquids in healthy, overweight people at steady-state concentrations","volume":"22","author":"Jones","year":"2020","journal-title":"Diabetes Obes Metabol"},{"issue":"12","key":"10.1016\/j.aan.2024.07.002_bib44","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/S2468-1253(17)30285-6","article-title":"Effects of liraglutide on weight, satiation, and gastric functions in obesity: a randomised, placebo-controlled pilot trial","volume":"2","author":"Halawi","year":"2017","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"4","key":"10.1016\/j.aan.2024.07.002_bib45","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1111\/dom.14944","article-title":"Semaglutide delays 4-hour gastric emptying in women with polycystic ovary syndrome and obesity","volume":"25","author":"Jensterle","year":"2023","journal-title":"Diabetes Obes Metabol"},{"issue":"1\u20133","key":"10.1016\/j.aan.2024.07.002_bib46","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.regpep.2008.07.003","article-title":"Effect of exenatide on gastric emptying and relationship to postprandial glycemia in type 2 diabetes","volume":"151","author":"Linnebjerg","year":"2008","journal-title":"Regul Pept"},{"issue":"2","key":"10.1016\/j.aan.2024.07.002_bib47","doi-asserted-by":"crossref","first-page":"785","DOI":"10.2337\/db13-0893","article-title":"Comparative effects of prolonged and intermittent stimulation of the glucagon-like peptide 1 receptor on gastric emptying and glycemia","volume":"63","author":"Umapathysivam","year":"2014","journal-title":"Diabetes"},{"issue":"5","key":"10.1016\/j.aan.2024.07.002_bib48","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1210\/jc.2005-2220","article-title":"Effects of intravenous glucagon-like peptide-1 on gastric emptying and intragastric distribution in healthy subjects: relationships with postprandial glycemic and insulinemic responses","volume":"91","author":"Little","year":"2006","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"11","key":"10.1016\/j.aan.2024.07.002_bib49","doi-asserted-by":"crossref","first-page":"3951","DOI":"10.1007\/s10620-020-06718-0","article-title":"Food Residue During Esophagogastroduodenoscopy Is Commonly Encountered and Is Not Pathognomonic of Delayed Gastric Emptying","volume":"66","author":"Bi","year":"2021","journal-title":"Dig Dis Sci"},{"issue":"8","key":"10.1016\/j.aan.2024.07.002_bib50","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1177\/10600280211055804","article-title":"Impact of Glucagon-Like Peptide-1 Receptor Agonists (GLP-1RA) on Food Content During Esophagogastroduodenoscopy (EGD)","volume":"56","author":"Stark","year":"2022","journal-title":"Ann Pharmacother"},{"issue":"6","key":"10.1016\/j.aan.2024.07.002_bib51","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1111\/jdi.14005","article-title":"Association of glucagon-like peptide-1 receptor agonist treatment with gastric residue in an esophagogastroduodenoscopy","volume":"14","author":"Kobori","year":"2023","journal-title":"J\u00a0Diabetes Investig"},{"key":"10.1016\/j.aan.2024.07.002_bib52","doi-asserted-by":"crossref","first-page":"111091","DOI":"10.1016\/j.jclinane.2023.111091","article-title":"Relationship between perioperative semaglutide use and residual gastric content: A retrospective analysis of patients undergoing elective upper endoscopy","volume":"87","author":"Silveira","year":"2023","journal-title":"J\u00a0Clin Anesth"},{"issue":"5","key":"10.1016\/j.aan.2024.07.002_bib53","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.diabet.2017.05.009","article-title":"Effect of GLP-1 receptor agonist on gastrointestinal tract motility and residue rates as evaluated by capsule endoscopy","volume":"43","author":"Nakatani","year":"2017","journal-title":"Diabetes Metab"},{"key":"10.1016\/j.aan.2024.07.002_bib54","doi-asserted-by":"crossref","DOI":"10.1001\/jamasurg.2024.0111","article-title":"Glucagon-Like Peptide-1 Receptor Agonist Use and Residual Gastric Content Before Anesthesia","author":"Sen","year":"2024","journal-title":"JAMA Surg"},{"key":"10.1016\/j.aan.2024.07.002_bib55","author":"Joshi"},{"issue":"8","key":"10.1016\/j.aan.2024.07.002_bib57","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1007\/s12630-023-02550-y","article-title":"Anesthesia and glucagon-like peptide-1 receptor agonists: proceed with caution","volume":"70","author":"Jones","year":"2023","journal-title":"Can J Anaesth"},{"issue":"1","key":"10.1016\/j.aan.2024.07.002_bib58","first-page":"216","article-title":"Anesthetic considerations in adult patients on glucagon-like peptide-1 receptor agonists: gastrointestinal focus","volume":"138","author":"Joshi","year":"2024","journal-title":"Anesth Analg"},{"issue":"4","key":"10.1016\/j.aan.2024.07.002_bib59","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s12630-017-1031-9","article-title":"Point-of-care gastric ultrasound and aspiration risk assessment: a narrative review","volume":"65","author":"Perlas","year":"2018","journal-title":"Can J Anaesth"},{"issue":"2","key":"10.1016\/j.aan.2024.07.002_bib60","first-page":"e01751","article-title":"Point-of-care gastric ultrasound to identify a full stomach on a diabetic patient taking a glucagon-like peptide 1 receptor agonist","volume":"18","author":"Giron-Arango","year":"2024","journal-title":"In Pract"},{"issue":"8","key":"10.1016\/j.aan.2024.07.002_bib61","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1007\/s12630-023-02549-5","article-title":"Influence of semaglutide use on the presence of residual gastric solids on gastric ultrasound: a prospective observational study in volunteers without obesity recently started on semaglutide","volume":"70","author":"Sherwin","year":"2023","journal-title":"Can J Anaesth"},{"issue":"3","key":"10.1016\/j.aan.2024.07.002_bib62","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1093\/bja\/aew435","article-title":"When fasted is not empty: a retrospective cohort study of gastric content in fasted surgical patientsdagger","volume":"118","author":"Van de Putte","year":"2017","journal-title":"Br J Anaesth"},{"issue":"1","key":"10.1016\/j.aan.2024.07.002_bib63","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1093\/bja\/aew400","article-title":"Ultrasound assessment of gastric volume in severely obese individuals: a validation study","volume":"118","author":"Kruisselbrink","year":"2017","journal-title":"Br J Anaesth"},{"issue":"4","key":"10.1016\/j.aan.2024.07.002_bib64","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.cgh.2023.11.002","article-title":"AGA Rapid Clinical Practice Update on the Management of Patients Taking GLP-1 Receptor Agonists Prior to Endoscopy: Communication","volume":"22","author":"Hashash","year":"2024","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"8","key":"10.1016\/j.aan.2024.07.002_bib65","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.14309\/ajg.0000000000001874","article-title":"ACG Clinical Guideline: Gastroparesis","volume":"117","author":"Camilleri","year":"2022","journal-title":"Am J Gastroenterol"},{"issue":"11","key":"10.1016\/j.aan.2024.07.002_bib66","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.2337\/diacare.16.11.1511","article-title":"Comparison of metoclopramide and erythromycin in the treatment of diabetic gastroparesis","volume":"16","author":"Erbas","year":"1993","journal-title":"Diabetes Care"},{"issue":"6","key":"10.1016\/j.aan.2024.07.002_bib67","doi-asserted-by":"crossref","first-page":"529","DOI":"10.23736\/S0375-9393.22.16913-0","article-title":"Ultrasonographic assessment of metoclopramide effect on gastric volume in parturients females undergoing Caesarean section: a randomized double blind study","volume":"89","author":"Hamed","year":"2023","journal-title":"Minerva Anestesiol"},{"issue":"9","key":"10.1016\/j.aan.2024.07.002_bib68","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1056\/NEJM200103013440908","article-title":"Aspiration pneumonitis and aspiration pneumonia","volume":"344","author":"Marik","year":"2001","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1016\/j.aan.2024.07.002_bib69","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1213\/00000539-199310000-00017","article-title":"Pathogenesis of gastric particulate lung injury: a comparison and interaction with acidic pneumonitis","volume":"77","author":"Knight","year":"1993","journal-title":"Anesth Analg"},{"issue":"4","key":"10.1016\/j.aan.2024.07.002_bib70","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1097\/00000542-198510000-00006","article-title":"Bicitra (sodium citrate) and metoclopramide in outpatient anesthesia for prophylaxis against aspiration pneumonitis","volume":"63","author":"Manchikanti","year":"1985","journal-title":"Anesthesiology"},{"issue":"8","key":"10.1016\/j.aan.2024.07.002_bib71","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1111\/j.1365-2036.2009.03947.x","article-title":"Effect of proton pump inhibition on the gastric volume: assessed by magnetic resonance imaging","volume":"29","author":"Babaei","year":"2009","journal-title":"Aliment Pharmacol Ther"},{"issue":"3","key":"10.1016\/j.aan.2024.07.002_bib72","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/anae.14915","article-title":"Reliability of gastric suctioning compared with ultrasound assessment of residual gastric volume: a prospective multicentre cohort study","volume":"75","author":"Bouvet","year":"2020","journal-title":"Anaesthesia"},{"issue":"3","key":"10.1016\/j.aan.2024.07.002_bib73","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1097\/01.mco.0000068970.34812.8b","article-title":"The nasogastric feeding tube as a risk factor for aspiration and aspiration pneumonia","volume":"6","author":"Gomes","year":"2003","journal-title":"Curr Opin Clin Nutr Metab Care"}],"container-title":["Advances in Anesthesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0737614624000029?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0737614624000029?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,21]],"date-time":"2024-10-21T20:14:06Z","timestamp":1729541646000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0737614624000029"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":71,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["S0737614624000029"],"URL":"https:\/\/doi.org\/10.1016\/j.aan.2024.07.002","relation":{},"ISSN":["0737-6146"],"issn-type":[{"value":"0737-6146","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Perioperative Considerations for Patients on GLP1 Agonists","name":"articletitle","label":"Article Title"},{"value":"Advances in Anesthesia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.aan.2024.07.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}